Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Adenovirus-Mediated Local Modification of Brain Genotype
14 February 2002. In theory, genetic manipulation is the only permanent method of altering the biochemistry of somatic cells. In practice, the concept faces many hurdles, not least being a safe and accurate method of delivering the right gene to the right place. In mice, for example, the use of Cre recombinase to splice out specific genes flanked by loxP DNA sequences, has been used with some success. However, this methodology requires crossing the Cre-expressing mice with those harboring loxP sites. Now, a paper in the February 12 PNAS online, demonstrates not only spatial, but temporal accuracy, in delivering Cre to, and ablating gene targets in, mouse somatic cells.

The technique, developed at Fred Gage's lab at the Salk Institute, La Jolla, California, combines the power for gene recombination of the Cre/loxP system with the low toxicity of the adeno-associated virus (AAV). The authors constructed an AAV vector containing a green fluorescent protein (GFP)-Cre fusion gene, driven by the cytomegalovirus (CMV) promoter. They first tested the vector in vitro, using HEK293 cells transfected with an inactive b-gal reporter gene; this gene is interrupted by a loxP-flanked stuffer region, which causes early termination of β-gal transcription and can be ablated by Cre-driven recombination. Expression of Cre in the cells was confirmed by GFP fluorescence, and recombination by expression of β-galactosidase. They then used the AAV in ROSA26 reporter mice, which have a similarly interrupted LacZ gene.-Tom Fagan.

Reference:Kaspar BK, Vissel B, Bengoechea T, Crone T, Randolph-Moore L, Muller R, Brandon E, Schaffer D, Verma I, Lee K-F, Heinemann S, Gage F. Adeno-associated virus effectively mediates conditional gene modification in the brain. PNAS 2002 February 19;99(4):2320-2325. Abstract

 
Comments on News and Primary Papers
  Comment by:  Karen Duff, ARF Advisor
Submitted 28 February 2002  |  Permalink Posted 28 February 2002

I think this is a good paper, and it adds to our transgenic toolbelt. It may, for example, allow us to turn pathology and off, to see if lesions such as plaques can be resolved once the source (e.g., elevated Aβ from an AβPP or PS1 transgene) is removed. Inducible transgenics have great advantages over constitutive ones, although there are also problems associated with the use of viral vectors. To be useful, though, it is important that new transgenic models in general be made with 'floxed' transgenes so that cre-directed control of transgene expression can be applied without having to make new mice.

View all comments by Karen Duff
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad